$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$96.26M
Market Cap
-
P/E Ratio
-8.57
EPS
$5.75
52 Week High
$1.78
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company based in Redwood City, California, specializing in innovative therapeutic solutions for rare diseases and ophthalmic disorders. The company is advancing a robust pipeline of gene therapy candidates utilizing its proprietary adeno-associated virus (AAV) technologies, designed to address significant unmet medical needs in the field. With a commitment to developing transformative treatments, Adverum is poised to improve patient outcomes and strengthen its foothold in the dynamic gene therapy sector.
LPTX
VMAR
IVP
NVDA
CGC
PFE
TSLA
WOK
AAL
PLUG
ASST
WBD
IRBT
RZLV
F
AVGO
ADAP
INTC
SNAP
PLTD
TLRY
BYND
BITF
DFLI
IREN
RIG
SOFI
CIFR
PLTR
MARA
GRAB
CRBG
DNN
T
NFLX
ALIT
HPE
APLD
BAC
ORCL
NIO
PBR
WULF
GOOGL
CPNG
LAZR
VHAI
PCG
BTBT
RGTI
QBTS
VALE
RILY
AMC
CORZ
UBER
KVUE
HBAN
NOK
AMD
VZ
RKLB
CCL
CLSK
MU
GOOG
MSTR
ITUB
HOOD
RR
SMCI
LPTX
VMAR
IVP
NVDA
CGC
PFE
TSLA
WOK
AAL
PLUG
ASST
WBD
IRBT
RZLV
F
AVGO
ADAP
INTC
SNAP
PLTD
TLRY
BYND
BITF
DFLI
IREN
RIG
SOFI
CIFR
PLTR
MARA
GRAB
CRBG
DNN
T
NFLX
ALIT
HPE
APLD
BAC
ORCL
NIO
PBR
WULF
GOOGL
CPNG
LAZR
VHAI
PCG
BTBT
RGTI
QBTS
VALE
RILY
AMC
CORZ
UBER
KVUE
HBAN
NOK
AMD
VZ
RKLB
CCL
CLSK
MU
GOOG
MSTR
ITUB
HOOD
RR
SMCI